Sapablursen

DB18608InvestigationalGene Therapies

Sapablursen is a synthetic 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide linked to a tri-antennary cluster of N-acetyl galactosamine (GalNAc3) sugars targeting transmembrane protease, serine 6 messenger ribonucleic acid.

Mechanism
Curator reviewed
Code names
IONIS TMPRSS6-LRx · ISIS-702843

Resolves to

What you can answer from here — as of October 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Sapablursen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account